,
KIDNEY CANCER CARE LIMITED
,
(A company limited by guarantee)
TRUSTEES' REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
CONTENTS AND ADMINISTRATIVE INFORMATION
CONTENTS PAGE: Trustees' Report 1-3 Independent Examiner's Report 4-5 Statement of Financial Activities 6 . Balance Sheet 7 Notes to the Financial Statements 8-16 TRUSTEES: B J Greenwood (Chairman) G Fox NI Cox G Oades Prof G D Stewart Dr E Boleti C D Thomas Prof M Tran Dr N Charley . COMPANY SECRETARY AND CHIEF OPERATING OFFICER: M Packer REGISTERED OFFICE: 4 New New Inn Lane
4 New New Inn Lane Guildford Surrey , GU4 7HW 05937304 1120146 and SC043642
COMPANY NUMBER: CHARITY INCORPORATION NUMBER: INDEPENDENT EXAMINER:
Ian Shipley FCCA For and on behalf of: Prentis & Co LLP Chartered Accountants & Independent Examiners 115c¢ Milton Road Cambridge CB4 1XE
VICE PRESIDENT:
Earl Freddie Howe
HONORARY VICE PRESIDENT: PATRON:
Tim O'Brien
Lord Addington
PAGE 1
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
TRUSTEES ANNUAL REPORT
The Trustees present their annual report together with the financial statements of the charity for the year ended 30th September 2025. The annual report serves the purposes ofboth a Trustees' Report and a directors report under company law. The Trustees confirm that the annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective Ist January 2019),
Since the charity qualifies as small under section 382 of the Companies Act 2006, the strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors’ Report) Regulations 2013 has been omitted.
OBJECTIVES AND ACTIVITIES AND PUBLIC BENEFIT
Policies and objectives
The policies and objectives of the charity are set and agreed at the charity's AGM which is held each year end. They focus on providing support for kidney cancer patients and their carers, raising awareness of the disease amongst the professional health community, the general public and government health planning audiences.
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance ‘Public benefit: running a charity (PB2)’.
ACHIEVEMENTS AND PERFORMANCE
Review of activities
Introduction to Kidney Cancer UK's Financial Statements 2025
Looking back on 2025, I would like to thank every member of the Kidney Cancer UK team for their dedication and commitment. Their efforts continue to underpin the charity's progress and impact. We remain the UK's leading kidney cancer charity, with a reach more than double that of other kidney cancer charities.
During the year, the charity continued to grow and strengthen its capacity to deliver effective and responsive services. A modest expansion of the office-based team required a move to larger premises nearby in Send, Woking. Limited further staff growth is anticipated in the coming year, building on our current team of four office-based staff to ensure delivery of our strategic objectives.
NHS services remain under significant strain due to pandemic backlogs and industrial action. Against this backdrop, Kidney Cancer UK has remained focused on supporting kidney cancer patients, their families and carers. We continue to mitigate the impact of treatment delays on patient wellbeing and to advocate for the routine use of our services, alongside those of other specialist cancer charities, within NHS care pathways.
Our free telephone Support Line has remained a vital service, alongside increased engagement in our closed Facebook support groups. Following the cessation of the Macmillan Counselling service, demand for our free counselling provision has increased. While a waiting list has been necessary, we have continued to meet demand within existing resources, with capacity in this area a priority for 2026.
The charity's digital presence continues to strengthen, with more than 3,000 members across four closed Facebook groups. Our Healthcare Professional website has also gained traction, with the Kidney Cancer HCP Training Programme remaining a widely used NHS resource. Membership now stands at almost 500 users.
PAGE 2
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
TRUSTEES ANNUAL REPORT ..........:0:000eseeeseseeeeeee/ CONTINUED
ACHIEVEMENTS AND PERFORMANCE- continued
The 12th Kidney Cancer UK Patient Survey, launched during Kidney Cancer Awareness Week in February, highlighted ongoing challenges for patients, including incidental diagnoses and dissatisfaction with NHS information and support. The survey helped to significantly raise the charity's international profile in 2025. During the year, I represented Kidney Cancer UK at four major conferences: The IKCC Madrid, IKCS Amsterdam and ESMO Berlin, and at BSIR 2025 in Liverpool. All attendances were supported by organiser grants. Reflecting the charity's growing influence, we have been invited to return to IKCS in 2026, this time to chair a session on the RCC patient experience.
A major milestone for patients will be the publication of the NICE guidance, for which the charity successfully campaigned, expected in spring 2026.
Despite a challenging fundraising environment, Kidney Cancer UK remains financially stable and well positioned for its next phase of development. We remain committed to strengthening fundraising, investing in patient services, and maintaining our role as the leading voice for kidney cancer support and advocacy in the UK.
FINANCIAL REVIEW
a. Going concern
After making appropriate enquiries, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.
.
b. Reserves policy
The charity received total income of £493,040 (2024: £289,934), it expended £265,927 (2024: £233,802) and had an overall surplus of £227,113 (2024: surplus £66,132).
Reserves stand at £379,872 (2024: £152,759), comprising unrestricted reserves of £315,749 and restricted reserves of £64,123. The charity had free reserves of £315,749 (2024: £84,445).
Funds have significantly increased this year due to the Charity receiving bequests and legacies of over £303 7K, £255K of this has been transferred into three new fixed rate deposit accounts. The Trustees have considered the level of free reserves that the charity holds, which currently stands at six months of our operating costs. It is their intention to build these further going forward.
.
STRUCTURE, GOVERNANCE AND MANAGEMENT
a. Constitution
Kidney Cancer Care Limited is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association on 15th September 2006. It is registered with the Charity Commission for England and Wales number 1120146 and Office of the Scottish Regulator number $C043642.
b. Methods of appointment or election of Trustees
The management of the charity is the responsibility of the Trustees who are elected and co-opted under the terms of the Memorandum of Association.
The Trustees who served during the year were:
B J Greenwood (Chairman) Dr G D Stewart G Fox Prof M Tran NI Cox C D Thomas G Oades Dr JN Perry (resigned 20/01/2025) Dr N Charnley Dr E Boleti
PAGE 3
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
TRUSTEES ANNUAL REPORT .o.....cccsseeseeseeseeeseesere/CONTINUED
STRUCTURE, GOVERNANCE AND MANAGEMENT- continued
ce. Organisational structure and decision-making policies
The day-to-day management lies with the office of the charity's Chief Operating Office (COO) acting in line with the objectives agreed by the Board of Trustees. The COO reports to the Chair of the Board of Trustees and, when required, briefs other members of the Board.
The Board of Trustees meets quarterly and is supported by the charity's senior management team. Our Trustees are drawn from a range of professional backgrounds and bring a wide range of relevant experience.
d. Members’ liability
The Members of the charity guarantee to contribute an amount not exceeding £1 to the assets of the charity in the event of winding up.
STATEMENT OF TRUSTEES' RESPONSIBILITIES
The Trustees (who are also the directors of the charity for the purposes of company law) are responsible for preparing the Trustees Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare the financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charity and ofits incoming resources and application of resources, including its income and expenditure, for that period, In preparing these financial statements, the Trustees are required to:
-
(a) select suitable accounting policies and then apply them consistently;
-
(b) observe the methods and principals of the Charities SORP (FRS 102);
-
{c) make judgements and accounting estimates that are reasonable and prudent;
-
(d) state whether applicable UK Accounting Standards (FRS102) have been followed, subject to any material departures disclosed and explained in the financial statements;
-
(e) prepare the financiai statements on a going concern basis unless it is inappropriate to presume the Charity will continue in operation.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the Board of Trustees and signed on their behalf by:
B J GREENWOODGX oo CHAIRMAN
DATE
KIDNEY CANCER CARE LIMITED
PAGE 4
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF KIDNEY CANCER CARE LIMITED
I report to the charity Trustees on my examination of the accounts of the charity for the year ended 30th September 2025.
RESPONSIBILITIES AND BASIS OF REPORT
As the Trustees of the charity (and its directors for the purposes of company law), you are responsible for the preparation of the accounts in accordance with the requirements of the Charities and Trustee Investment (Scotland) Act 2005 (‘the 2005 Act’), the Charities Accounts (Scotland) Regulations 2006 (as amended) (‘the 2006 Accounts Regulations’) and the Companies Act 2006 (‘the 2006 Act’). You are satisfied that the accounts of the charity are not required by charity or company law to be audited and have chosen instead to have an independent examination.
Having satisfied myself that the accounts of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect ofmy examination of the charity's accounts carried out under section 44(1)(c)of the 2005 Act and section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the requirements of Regulation 11 of the 2006 Accounts Regulations and the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
INDEPENDENT EXAMINER'S STATEMENT
Since the charity is required by company law to prepare its accounts on an accrual basis and is registered as a charity in Scotland, your examiner must be a member of a body listed in Regulation 11(2) of the 2006 Accounts Regulations. I can confirm that J am qualified to undertake the examination because I ama registered member of the Association of Chartered Certified Accountants, which is one of the listed bodies.
Ihave completed my examination. I confirm that no material matters have come to my attention in connection with the
examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act and Regulation 4 of the 2006 Accounts Regulations; or
-
the accounts do not accord with those records and with the accounting requirements of Regulation 8 of the 2006 Accounts Regulations; or
-
3, the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or
-
4, the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102)].
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
PAGE 5
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
:
INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF KIDNEY CANCER CARE LIMITED
This report is made solely to the charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008 and Regulation 11 of the Charities Accounts (Scotland) Regulations 2006. My work has been undertaken so that I might state to the charity's Trustees those matters I am required to state to them in an independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the charity and the charity's Trustees as a body, for my work or this report.
ove£ > Ses IAN SHIPLEY FCCA FOR AND ON BEHALF: PRENTIS & CO LLP CHARTERED ACCOUNTANTS & INDEPENDENT EXAMINERS
;
115c¢ Milton Road Cambridge CB4 1XE JL& Ferrey UG
|XO
ea
0
=
Ps|mm oy
St
B99
Sala
s/s
A
ae
CHM aR HOOD
a
18
—
ar
eo
cea la
cn |en
Rel
ola
06
ma)
N 1A
Na)
oo
|
N
N
NIN
—|
|---|---|
||.|
||oma
S88
SRlg
ej2|/
ge!
gI¥
ofaAans
|S
= |
—t
OD |
‘6
on
|
ast iw
~
oO |x
a
=
=
als
™
|0
g
N
nN
ala
a)|
||Bes
a's
Sig|
S|
Biz
SERRA
IA
Biel
Ql
6 lr
Oe
90
me)
NLS
06
aH
|oo
A
™
ld
Cn
kona!
Wy
\o|
||fam|
||= 4
=m s/o
mye
ra
an IN
BUS
oasls
N 1A
=
m
|&
ei
ALA
—
a ha
ee
oo
tf | on
wf
~
Slax
ro)
of
eo
|
nN
wa 1s
t
t
A Ian
Nn
= leq|
||3 4
ezga
ss |s
S/S
3
TIA\
NA\
my,\
|S\
EB pe\
A+ [&\
wn | 4\
om\
ae\
A\
w\
"\
NEN\
cn\
oOo i=\
zg\
+\
\
N\
A\
ve)|
||a\
4\
=\
ZE8\
sf\
'\
lg]\
gig]\
F]\
Sig\
BARA\
|\
eSic|\
a=]\
mia\
pee\
"Ss\
(6)\
gig)\
f]\
eg|
||as|
||FF|
||uo|
||w>\
N\
o\
2\
c=)\
»\
&\
BA\
3\
5F\
aFh,\
=\
5}\
ey\
[F)\
[aa\
a)\
72)\
A\
wi|
||S\
=\
5|
|A\
a\
PA\
=\
3\
=\
‘5\
oy\
=\
5\
z\
2\
&\
A\
wn\
ee)\
o\
og\
cs\
PA)\
ea\
2\
=\
a\
>
SN
t
g
oe
pe
Eg
#
:
oO
Eg
3
2
EB
&
3
2
5
2
2
>
E
na
<
Fa
oS
wl
ax
Oo
<t
o
fx
Oo
™
wi
a2
f
soo
3
2
2
2
£
2565
3
:
3)
q
8
42s
§&
a
:
Ee
fa
3
nm &
Zz
°
A=|
oo
m
a
oR
GF Og
ey
A
<<
So
2
zen
8
oe
Y
O
O
2
5
BB
&
6
=
a
A
es}
e)
6 o
Ss <2 &
4
o
Seg
.3,2
FRE
28,2
Fs
—
ao
og
3G
2 og
8225
222
2252
|
:
B
a
See
<
Ag 2
zoe s
“a
=]
ee
$825
85
GREE
&
:
nn)
A4aQ8
&
AO
Bee
sg
B
=||
PAGE 7
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
BALANCE SHEET
==> picture [420 x 318] intentionally omitted <==
----- Start of picture text -----
||||||||
|---|---|---|---|---|---|---|
|2025|2024|
|Notes|£|£|£|£|
|FIXED|ASSETS|-|-|
|Tangible|assets|8|
|CURRENT ASSETS|
|Stocks|9|2,866|3,164|
|Debtors|10|7,963|6,003|
|Cash at bank|and|in hand|373,830|160,63|1|
|TOTAL CURRENT ASSETS|384,659|169,798|
|CURRENT|LIABILITIES|
|Creditors:|Amounts|falling|due|
|within|one|year|11|:|4,787|17,039|
|NET CURRENT ASSETS|379,872|152,759|
|TOTALNET ASSETS|379,872|152,759|
|THE|FUNDS|OF|THE|CHARITY|12|
|Restricted|funds|64,123|68,314|
|Unrestricted|funds|315,749|84,445|
|TOTAL CHARITY FUNDS|379,872|152,759|
----- End of picture text -----
The directors consider that the charitable company is entitled to exemption from the requirement to have an audit under the provisions of Section 477(1) of the Companies Act 2006. Members have not required the company under Section 476 of the Companies Act 2.006, to obtain an audit for the year ended 30th September 2025. The directors acknowledge their responsibilities for ensuring that the charitable company keeps accounting records which comply with Section 386 and 287 of the Companies Act 2006 and for preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at 30th September 2025 and of its surplus for the year then ended in accordance with the requirements of Section 396 and which otherwise comply with the requirements of the Act relating to the financial statements as far as applicable to the charitable company, The financial statements, which have been prepared in accordance with the special provisions relating to companies subject to the smail companies regime within Part 15 ofthe Companies Act 2006, were approved by the board on 3 / z./ and signed on its behalf. Ze BJ pene Cas : CHAIRMAN '
The notes on pages 8 to 16 form part of these financial statements.
PAGE 8
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
NOTES TO THE FINANCIAL STATEMENTS
1. ACCOUNTING POLICIES (a) BASIS OF PREPARATION OF FINANCIAL STATEMENTS
The financial statements have been prepared in accordance with the Charities SORP (FRS102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1st January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), Companies Act 2006, The Charities Accounts (Scotland) Regulations 2006 and the Charities and Trustee Investment (Scotland) Act 2005.
Kidney Cancer Care Limited meets the definition of a public benefit entity under FRS102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
The financial statements are presented in sterling, which is the functional currency of the charity.
The Trustees have taken advantage of the amendment to the Charities SORP FRS 102, where only larger charities are required to prepare a Statement of Cash Flows.
(b) CHARITY STATUS
The charity is a company limited by guarantee. The members of the charity are the Trustees. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member.
(c) INCOME
All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
The recognition of income from legacies is dependent on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the charity has sufficient evidence that a gift has been left to them (through knowledge of the existence ofa valid will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the charity, can be reliably measured.
Grants are included in the Statement of Financial Activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant fund on the balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.
Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of donation.
Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.
Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service.
KIDNEY CANCER CARE LIMITED
PAGE 9
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
NOTES TO THE FINANCIAL STATEMENTS
- ACCOUNTING POLICIES- continued
(d) EXPENDITURE
Expenditure is recognised once there is a legal or constructive obligation to transfer the economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.
Fundraising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of charitable activities. Governance costs are those incurred in connection with administration of the Fund and compliance with constitutional and statutory requirements.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the charity's objectives, as well as any associated support costs.
Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.
(ec) TANGIBLE FIXED ASSETS AND DEPRECIATION Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.
Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, using the straight-line method.
Depreciation is provided on the following basis:
Plant and machinery 50% straight line
(f) OPERATING LEASES
Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight line basis over the lease term.
(g) PENSIONS
The charity contributes to personal pension plans of its employees and the pension charge represents the amounts payable by the charity to the plans in respect of the year.
(h) FUND ACCOUNTING
General funds are unrestricted which are available for use at the discretion of the Trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements,
= eai) < a
BSS |E8e88 8§$ BSR SHARlow] HORA A TSE le oe Omrnnm mo on mm | OO Ate A a) ‘© | 98 iceo] + o 248 eeseas = g's PERERA haaan A 4 " 5 CON Om ca “ oS oO Nth wa nq = on) B88 48°38' ' 'S$]s BM “- 2 6 |e ww
g3sa orwocsotTaANnS eH on= enatcn | eaTt Esaweagen f& HAS nm nMomws 0 rn oO | N MW ™ N & B28Ww gae'g 2 g' ig SeSudNS 2 S GR Is BeoOwnParl aga 7 ce= awT ca He) 32 @ '«& ' oi: 1 log ls oS o oS em | en SEA oS Qo a fo ar: 5s | %, pe
Ww Ol come) N oe : Ay ) ea) ” & =A B fr < faa B QO—t aa A ef ¢ . S 2 B 7 << E | oO n § 3 33 5 BH HS i nn - a & _ £ 8 s a Os Z ie) (@) is) ah & = a & = sos 2Rm £2 Bygs 2i] aPo5 Oo << FF 6 § 3 Qs pa B fe) a) a ks) gs wo a BE © ¢ ge 868 6 & ya Ses aS} og = a2 2Do ¢ow 628Eee,ebSBCe8253ee ES GB 2-E fe)g& x gEaglOsREAR5B PEagneoORSOESese:
KIDNEY CANCER CARE LIMITED
PAGE 11
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
NOTES TO THE FINANCIAL STATEMENTS
| 3, | INVESTMENTINCOME | Restricted Unrestricted | Restricted Unrestricted | Restricted Unrestricted | Total | |
|---|---|---|---|---|---|---|
| Currentyear | Funds | Funds | Funds | |||
| 2025 | 2025 | 2025 | ||||
| £ | £ | £ | ||||
| Bank interestreceivable | - | 4,403 | 4,403 | |||
| Restricted | Unrestricted | Total | ||||
| Prioryear | Funds | Funds | Funds | |||
| 2024 | 2024 | 2024 | ||||
| £ | £ | £ | ||||
| Bank interest receivable | - | 1,096 | 1,096 | |||
| 4. | ANALYSIS OFEXPENDITUREONCHARITABLEACTIVITIES | ACTIVITIES _ | Restricted | Unrestricted | Total | |
| : | Summarybyfund type | Funds | Funds | Funds | ||
| Currentyear | 2025 | 2025 | 2025 | |||
| £ | £ | £ | ||||
| Patient advice andinformationsupport services | 40,025 | 210,876 | 250,901 | |||
| Fundraising | - | 15,026 | 15,026 | |||
| 40,025 | 225,902 | 265,927 | ||||
| Restricted | Unrestricted | Total | ||||
| Prioryear | Funds | Funds | Funds | |||
| 2024 | 2024 | 2024 | ||||
| £ | £ | £ | ||||
| Patientadvice and information support services | 19,500 | 186,781 | 206,281 | |||
| Fundraising | 132 | 17,389 | 17,521. | |||
| 19,632 | 204,170 | 223,802 | ||||
| 5. | ANALYSISOFEXPENDITUREBYACTIVITIES | Activities | Grant | |||
| Current year | undertaken | funding of | Support | Total | ||
| directly | activities | Cost | funds | |||
| 2025 | 2025 | 2025 | 2025 | |||
| £ | £ | £ | £ | |||
| Patient advice andinformation support services | 252,528 | (12,818) | 11,191 | 250,901 | ||
| Fundraising | 15,026 | . | - | 15,026 | ||
| 267,554 | (12,818) | 11,191 | 265,927 |
The grant funding of activities in 2025 represents grants repaid to the Charity and previously accrued grants now written off.
KIDNEY CANCER CARE LIMITED
PAGE 12
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
NOTES TO THE FINANCIAL STATEMENTS
| 5. | ANALYSIS OFEXPENDITUREBYACTIVITIES - continued | ANALYSIS OFEXPENDITUREBYACTIVITIES - continued | |||
|---|---|---|---|---|---|
| Activities | Grant | ||||
| Prioryear | undertaken | funding of | Support | Total | |
| directly | activities | Cost | funds | ||
| 2024 | 2024 | 2024 | 2024 | ||
| £ | £ | £ | £ | ||
| Patient adviceandinformationsupport services | 195,130 | 1,500 | 9,651 | 206,281 | |
| Fundraising | 17,521 | - | - | 17,521 | |
| 212,651 | 1,500 | 9,651 | 223,802 | ||
| Analysis ofdirect costs | Patient support | Total | |||
| Currentyear | andinformation | Fundraising | funds | ||
| 2025 | 2025 | 2025 | |||
| £ | £ | £ | |||
| Staffcosts (note 6) | 160,167 | - | 160,167 | ||
| Fundraising costs | - | 15,026 | 15,026 | ||
| Establishment costs | 2,750 | - | 2,750 | ||
| Bankcharges | 359 | - | 359 | ||
| Patient support | $9,270 | - | §9,270 | ||
| Printing, postageand stationery | 6,168 | - | 6,168 | ||
| Subscriptions anddonations | 1,675 | - | 1,675 | ||
| Repairsandmaintenance | 1,209 | - | 1,209 | ||
| Travel and subsistence | 2,892 | - | 2,892 | ||
| Advertisingandpromotion | 3,435 | - | 3,435 | ||
| Training, conference andmeeting costs | 118 | - | 118 | ||
| Insurance | 308 | - | 308 | ||
| Rent and rates | 9,282 | - | 9,282 | ||
| Website and internetexpenses | 4,895 | - | 4,895 | ||
| 252,528 | 15,026 | 267,554 |
PAGE 13
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
NOTES TO THE FINANCIAL STATEMENTS
- ANALYSIS OF EXPENDITURE BY ACTIVITIES- continued
| Analysis ofdirect costs | Analysis ofdirect costs | Patient support | Total | |
|---|---|---|---|---|
| Prioryear | and information | Fundraising | funds | |
| 2024 2024 |
2024 | |||
| £ | £ | £ | ||
| Staffcosts (note 6) | 109,735 | - | 109,735 | |
| Fundraising costs | - | 17,521 | 17,521 | |
| Establishment costs | 3,593 | - | 3,593 | |
| Bank charges | 354 | - | 354 | |
| Patientsupport | 12,578 | - | 12,578 | |
| Printing, postage and | stationery | 9,276 | - | 9,276 |
| Subscriptions and donations | 1,274 | - | 1,274 | |
| Repairs andmaintenance | 65 | - | 65 | |
| Travel and subsistence | 2,680 | - | 2,680 | |
| Advertising and promotion | 26,046 | -~ | 26,046 | |
| Training, conference | andmeeting costs | 177 | - | 177 |
| Insurance | 884 | - | 884 | |
| Rent and rates | 5,442 | - | 5,442 | |
| Website and internet | expenses | 23,013 | - | 23,013 |
| Sundry expenses | : | 13 | - | 13 |
| 195,130 | 17,521 | 212,651 | ||
| Analysis ofsupport | costs | Patientsupport | Total | |
| Current year | andinformation | information | funds | |
| 2025 | 2025 | |||
| £ | £ | |||
| Professional fees (incl. IE fees) | 11,191 | 11,191 | ||
| Analysis ofsupport | costs | Patient support | Total | |
| Prioryear | and | information | funds | |
| 2024 | 2024 | |||
| £ | £ | |||
| Professionalfees(incl.IEfees) | 9,651 | 9,651 |
PAGE 14
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
NOTES TO THE FINANCIAL STATEMENTS
==> picture [482 x 166] intentionally omitted <==
----- Start of picture text -----
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|6.|STAFF|COSTS|2025|2024|
|£|£|
|Wages|and|salaries|147,469|98,090|
|Social|security|costs|4,333|2,777|
|Pension|costs|4,124|3,883|
|Other|staff costs|4,241|4,985|
|160,167|109,735|
|The|average|number|of|personnel|employed by the|charity|during|the year was|as|follows:|
|2025|2024|
|Patient|care|and|admin|7|5|
----- End of picture text -----
No employee received remuneration amounting to more than £60,000 in either year.
- TRUSTEES' REMUNERATION AND EXPENSES During the year ended 30th September 2025 no Trustees received any remuneration or other benefits (2024: £Nil).
==> picture [485 x 259] intentionally omitted <==
----- Start of picture text -----
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|During|the|year|ended|30th|September 2025|no|Trustee|expenses|have|been|incurred (2024:|£Nil).|
|8.|FIXED ASSETS|Plant|and|Plant|and|
|Machinery|Machinery|
|2025|2024|
|COST|OR VALUATION|£|£|
|At|Ist|October|and|30th|September|5,862|5,862|
|DEPRECIATION|
|At|1st|October and|30th|September|5,862|5,862|
|NET BOOK VALUE AT|30th|September|-|-|
|9.|STOCKS|2025|2024|
|£|£|
|Goods|for|resale|2,866|3,164|
|10.|DEBTORS|2025|2024|
|Due|within|one year|£|£|
|Prepayments|and accrued income|7,963|6,003|
----- End of picture text -----
PAGE 15
KIDNEY CANCER CARE LIMITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
NOTES TO THE FINANCIAL STATEMENTS
==> picture [484 x 519] intentionally omitted <==
----- Start of picture text -----
||||||||
|---|---|---|---|---|---|---|
|11.|CREDITORS|2025|2024|
|Amounts|falling|due|within|one year|£|£|
|Trade|creditors|277|928|
|Other|taxation|and|social|security|404|993|
|Other|creditors|958|1,111|
|Accruals|and deferred|income|3,148|14,007|
|4,787|17,039|
|12.|STATEMENT OF FUNDS|Balance|at|Balance|at|
|Current year|Ist|30th|
|October|September|
|2024|Income|Expenditure|2025|
|Unrestricted|funds|£|£|£|£|
|General Funds|84.445|457,206|(225,902)|315,749|
|Restricted|funds|
|Kidney|Cancer Awareness|61,666|26,834|(32,975)|55,525|
|Healthcare|Professional website|redevelopment|6,600|-|(6,600)|-|
|Bristol Myer|- Audio books|-|5,000|(450)|= 4,550|
|Private|donations|for Research|48|4,000|-|4,048|
|68,314|35,834|(40,025)|64,123|
|TOTAL OF FUNDS|152,759|493,040|(265,927)|379,872|
|STATEMENT OF FUNDS|Balance|at|Balance|at|
|Prior year|1st|30th|
|October|September|
|2023|Income|Expenditure|2024|
|Unrestricted|funds|£|£|£|£|
|General Funds|76,972|211,643|(204,170)|84,445|
|Restricted|funds|
|Kidney Cancer Awareness|9,607|61,666|(9,607)|61,666|
|Research Grants|(University of Cambridge)|-|1,500|(1,500)|-|
|Healthcare|Professional website|redevelopment|-|15,000|(8,400)|6,600|
|Private|donations|for Research|48|125|(125)|48|
|9.655|78,291|(19,632)|68,314|
|TOTAL|OF FUNDS|86,627|289,934|(223,802)|152,759|
----- End of picture text -----
KIDNEY CANCER CARE LIMITED
PAGE 16
FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH SEPTEMBER 2025
NOTES TO THE FINANCIAL STATEMENTS
- STATEMENT OF FUNDS- continued
Restricted Funds
Kidney Cancer Awareness: grants awarded over 3 years to 2026/27 for awareness campaigning. Healthcare Professional Website redevelopment: development of a healthcare specific website. The Private donations for Research were given by members of the public specifically requesting they be used for research.
Bristol Myer - Audio books: grant awarded towards the purchase of audio books which provide further understanding of kidney cancer.
==> picture [483 x 212] intentionally omitted <==
----- Start of picture text -----
|||||||||
|---|---|---|---|---|---|---|---|
|13.|ANALYSIS OF NET ASSETS BETWEEN FUNDS|Restricted|Unrestricted|Total|
|Current year|Funds|Funds|Funds|
|2025|2025|2025|
|£|£|£|
|Current|assets|64,123|320,536|384,659|
|Creditors|due|within|one|year|-|(4,787)|(4,787)|
|TOTAL|64,123|315,749|379,872|
|ANALYSIS|OF NET ASSETS BETWEEN FUNDS|Restricted|Unrestricted|Total|
|Prior year|Funds|Funds|Funds|
|2024|2024|2024|
|£|£|£|
|Current|assets|68,314|101,484|169,798|
|Creditors|due|within one year|-|(17,039)|(17,039)|
|TOTAL|68,314|84,445|152,759|
----- End of picture text -----
14.
PENSION COMMITMENTS The charity contributes to employees' personal pension schemes. The pension cost charge represents contributions payable by the charity to the schemes and amounted to £4,124 (2024: £3,883). Contributions totalling £826 (2024: £353) were payable to the schemes at the balance sheet date and are included in creditors.
- OPERATING LEASE COMMITMENTS
At 30th September 2025 the charity had commitments to make future minimum lease payments under non-cancellable operating leases as follows:
==> picture [426 x 83] intentionally omitted <==
----- Start of picture text -----
||||||||||
|---|---|---|---|---|---|---|---|---|
|2025|2024|
|£|£|
|Within|1|year|14,400|7,200|
|RELATED PARTY TRANSACTIONS|
|Total|amount|received|from|Trustees|in the year were|£Nil|(2024:|£Nil).|
----- End of picture text -----